Author:
Pagnano Katia B.,Varela Ana Ines,Pavlovsky Carolina,Bendit Israel,Funke Vaneuza A. M.,Polo Virginia Abello
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference53 articles.
1. Cortes J, De Souza C, Ayala-Sanchez M, Bendit I, Best-Aguilera C, Enrico A, et al. Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET). Cancer. 2010;116(21):4991–5000.
2. Pavlovsky C, Mela Osorio MJ. Chronic myeloid leukemia: what is the best strategy to start and monitor treatment outside academic centers? Curr Oncol Rep. 2018;20(1):4.
3. Abello-Polo VS-M, Claudia Peña, Angela et al. ACHO (Asociación Colombiana de Hematología y Oncología), RENEHOC researchers. Impact of Insurance Differences in Outcomes in Colombian Patients with Chronic Myeloid Leukemia (CML). Clinical Lymphoma, Myeloma and Leukemia. 2020:S240
4. Méndez Y, Giraldo-Castaño Mn, Rocha MF. Estudio sobre la identificación de necesidades emocionales, sociales y de acceso a los servicios de salud, de los pacientes diagnosticados con leucemia mieloide crónica en Colombia https://www.funleucemialinfoma.org/wp-content/uploads/2019/07/Paper-Estudio-LMC.pdf: Fundación Colombiana de Leucemia y Linfoma; 2018. Accessed 11 Apr 2021.
5. Ylescas-Soria J, de la Torre-Lujan AH, Herrera LA, Miranda D, Grimaldo F, Rivas S, et al. Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute - Mexico, from 2000 to 2016. Cancer Med. 2019;8(6):2942–9.